Interesting, page-4814

Paul, you nailed it. Just as Imagion in its current Phase1 clinical study is using an imaging agent that's
designed specifically for breast cancer patients (HER2), NewPhase are 'Tweaking' their SPION's manufactured
by Imagion.
Perhaps those repetitious idiotic comments by that one poster stating that Imagion was no longer supplying
NewPhase with SPION's will finally get it.

As communicated by the company in their 'Half-Year Results' the move to the new premises in San Diego
is anticipated for Nov - Dec 2021. This will give the Co more control over product development and commercial
manufacturing. A very positive move, Indeed.